Penumbra, Inc. to Present at the Canaccord Genuity 39th Annual Growth Conference

ALAMEDA, Calif., July 17, 2019 — Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Canaccord Genuity 39th Annual Growth Conference in Boston, MA on Wednesday, August 7, 2019.

Penumbra, Inc. Logo (PRNewsFoto/Penumbra, Inc.)

Event: Canaccord Genuity 39th Annual Growth Conference
Date: Wednesday, August 7, 2019
Time: 11:00am ET / 8:00am PT

A webcast of the presentation will be available by visiting the investors’ section of the company’s website at The webcast will be available on the company’s website for at least two weeks following the event.

About Penumbra
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets medical devices and has a broad portfolio of products that addresses challenging medical conditions and significant clinical needs. Penumbra sells its products to hospitals primarily through its direct sales organization in the United States, most of Europe, Canada and Australia, and through distributors in select international markets. The Penumbra P logo is a trademark of Penumbra, Inc. For more information, visit

Investor Relations
Penumbra, Inc.
[email protected]

Cision View original content to download multimedia:

SOURCE Penumbra, Inc.


Contact us to learn more about our products and company